Ofichem Group is a family-owned European CDMO and pharmaceutical supplier founded in 1975, headquartered in Ter Apel, Netherlands. The company provides end-to-end services from drug substance (API) development through finished drug product manufacturing, including sourcing and distribution. Ofichem has recently expanded through acquisitions of Meribel Pharma Solutions' Uppsala site (early-phase development, ADCs, oligonucleotides, PROTACs) and Avivia (formulation development).
API development and GMP manufacturing, drug product formulation, pharmaceutical sourcing and distribution, early-phase drug substance development, ADC and oligonucleotide chemistry
2 sites worldwide
No reviews available yet.
No documents available.